Jan 25, 2022 11:41 AM EST Following Its Recent Annual Updates: IR-Med Announces OTCQB Up-listing: “A Significant Achievement for the Company”
Jan 12, 2022 11:15 AM EST IR-Med to Announce 2022 Goals: Anticipated POC Results, File for FDA Clearance and up Listing to the OTCQB
Jun 25, 2021 4:47 PM EDT IR-Med, Inc. Announces the Appointment of Dr. Rom Eliaz as Chief Executive Officer
Apr 08, 2021 2:13 PM EDT IR-Med, Inc. Announces the Resignation of Limor Davidson Mund as CEO and Appointment of Chairman of the Board Oded Bashan as Interim Chief Executive Officer
Jan 20, 2021 8:23 AM EST IR-Med, Inc. Announces FINRA Approval of Name Change and Ticker Symbol Change to “IRME”